As a Group Leader and Jenner Investigator at the Jenner Institute, University of Oxford. Dr. López-Camacho is pioneering the in-house development of an mRNA vaccine-based platform. His innovative work uses novel Lipid Nanoparticles (LNPs) for encapsulation and development of new generation of mRNA-based vaccines, supported by funding from a JFF grant and a NIHR Capital Fund. Based on these achievements his group is constructing a mRNA core facility in order to make mRNA technologies, in the pre-clinical setting, available to internal and external researchers. His group is also at the forefront of vaccine development against viruses transmitted by ticks, and mosquitos as well as tick antigens, comprising postdoctoral scientists, DPhil students and research assistants.